In April, we worked alongside the Academy of Medical Sciences outlining the priorities for a mental health research response to coronavirus, which was published in the Lancet Psychiatry. The Lancet has since published a further paper that builds on the community's response, outlining five areas that need to be at the front and centre of the ongoing mental health research response to the pandemic.
We're delighted to announce that Lea Milligan has been appointed as MQ's new Chief Executive. He will take up the post at the end of June.
A new paper published today in Lancet Psychiatry highlights an urgent need to tackle the harmful impacts of the COVID-19 pandemic on mental health.
A key part of MQ’s mission is to cultivate a research community dedicated to tackling the big challenges in mental health. One way we do that is through our Fellows Awards, funding talented scientists to become the next generation of research leaders.
MQ and the Academy of Medical Sciences have rapidly convened an expert group to develop mental health and neuroscience research priorities to COVID-19.
There is growing recognition that the mental health impacts of the coronavirus (COVID-19) pandemic will be significant for us all – for those with existing mental health conditions and for everyone affected by stress, anxiety, isolation, loneliness, family pressure and financial hardship.
In new research, MQ Fellow Dr Ethel Nakimuli-Mpungu has successfully trialled an innovative way to increase access to effective mental health care in Sub-Saharan Africa.
A report published today shows that in 2018 mental health research received 6.1% of the overall UK health research budget - an increase of 0.51% since 2014.